Italia markets closed

BMY May 2024 43.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,6000-0,7000 (-21,21%)
Alla chiusura: 02:43PM EDT
Schermo intero
Chiusura precedente3,1500
Aperto2,6300
Denaro1,4000
Domanda4,5000
Prezzo d'esercizio43,50
Scadenza2024-05-31
Min-Max giorno2,4500 - 2,6300
Contratto - Min-MaxN/D
Volume6
Open Interest226
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri